Targeting Stress-Adaptive States: An Emerging Framework in Cancer Pharmacology.
The failure of cancer therapy is largely driven by the remarkable capacity of tumor cells to adapt to pharmacological stress. Beyond genetic alterations and signaling pathway rewiring, malignant cells exploit dynamic stress-adaptive protein states that promote survival under cytotoxic conditions. Rather than providing...